'Combination Product Agreement Meetings' Coming Soon From US FDA
Executive Summary
The meetings are tied to requirements from the 2016 21st Century Cures legislation. They could offer more development certainty for sponsors by allowing informal agreements with the agency on pre- and post-market issues.
You may also be interested in...
Final Combo Product GMP Requirements Are More Of The Same; Encourage FDA Meetings
A recent Federal Register Notice on GMP requirements for combination products doesn’t change any of the fundamental expectations and requirements laid out in a previous 2018 draft, but does add clarification for sponsors.
More Talk, Less Work: US FDA Outlines Expectations For Combo Products Discussions
New FDA draft guidance says manufacturers of combination products should first review existing combination product guidances and submit questions before asking for a combination product agreement meeting with regulators to get clarification. The guidance outlines what is expected of both sides in such meetings.
More Talk, Less Work: US FDA Outlines Expectations For Combo Products Discussions
A new FDA draft guidance says manufacturers of combination products should first review existing combination product guidances and submit questions before asking for a combination product agreement meeting with regulators to get clarification. The guidance outlines what is expected of both sides in such meetings.